• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Out-of-Pocket Healthcare Expenditures in the United States

$796.00 – $1,592.00

Clear
SKU: KLI15319908 Categories: Healthcare Market Research, Insurance & Managed Care Pages: 51
  • Description
  • Table of Contents
  • Latest reports

Description

Out-of-Pocket Healthcare Expenditures in the United States

Out-of-Pocket Healthcare Expenditures in the United States examines the average person’s out-of-pocket medical costs, including:

  • Distribution of Out-of-Pocket Spending for the Average Person, 2016, 2021
  • Consumer Out-of-Pocket Expenditures per Worker, 2011–2021
  • Consumer Out-of-Pocket Expenditures by Type, 2011–2021
  • Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2011, 2016, 2021
  • Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Percentile of Total Health Spending and Type of Service, 2016
  • Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Type of Service, 2016
  • Consumer Out-of-Pocket Healthcare Expenditures by Payment Type, 2016

The report contains analysis and forecasts to 2021. It details consumer mechanisms of outlay by amount of spending, including loans and lines of credit, flexible spending accounts (FSAs), health savings accounts (HSAs), credit cards and cash or check. Out-of-Pocket Healthcare Expenditures in the United States also outlines expenditures by type, including the consumer costs of prescription medications, office-based procedures, and hospital stays.

Table of Contents

1: EXECUTIVE SUMMARY

OVERVIEW

PAYMENT METHODS

PRESCRIPTION MEDICATIONS

FORECAST

Table 1-1: Consumer Out-of-Pocket Expenditures per Worker, 2016 and 2021

2: INTRODUCTION: OUT-OF-POCKET EXPENDITURES, THE MARKET IN 2017

TYPES OF EXPENDITURES

Insurance Co-Payments

Direct Payments

Premiums and Plan Fees

PAYMENT METHODS

Figure 2-1: Consumer Out-of-Pocket Healthcare Expenditures by Payment Type, 2016

Cash or Check

Credit Cards

Loans and Lines of Credit

Flexible Spending Accounts

Health Savings Accounts

AMOUNT FINANCED

Non-Elective Procedures and Prescription Drugs

Figure 2-2: Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Type of Service, 2016

Figure 2-3: Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Percentile of Total Health Spending and Type of Service, 2016

Figure 2-4: Distribution of Out-of-Pocket Healthcare Spending for the Average Person, 2016

Figure 2-5: Distribution of Out-of-Pocket Spending for the Average Person, by Spending Level, 2016

Figure 2-6: Drug Cost Coverage by Payor Type (Public, Private, Cash): 1965, 1986, 2000, 2005, 2010, 2016

CONSUMERS WHO PAY OUT-OF-POCKET

The Uninsured and Underinsured

Medicaid Recipients

The Disabled

Senior Citizens

The Mentally Ill

The Obese

Table 2-1: Obesity in the United States, 1980 – 2021

Persons with Alcohol and Drug Addictions

Figure 2-7: National Overdose Deaths from Prescription Drugs, 2001 – 2014

Figure 2-8: National Overdose Number of Deaths from Heroin, 2001 – 2014

Persons with Chronic Conditions

Figure 2-9: Type of Insurance Coverage for Adults between the Ages of 18 and 65 with Chronic Conditions, 2016

3: MARKET ANALYSIS: GROWTH FROM 2016 – 2021

TRENDS

Out-of-Pocket Expenditure Growth Drivers

Out-of-Pocket Expenditure Growth Constraints

FORECASTS

Table 3-1: Consumer Out-of-Pocket Expenditures per Worker, 2011–2021

Expenditures by Type

Table 3-2: Consumer Out-of-Pocket Expenditures by Type, 2011–2021

Figure 3-1: Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2011, 2016, 2021

Payment Methods

Table 3-3: Consumer Out-of-Pocket Expenditures by Type, 2011–2021

Figure 3-2: Proportion of Consumer Out-of-Pocket Spending by Payment Type, 2011, 2016, 2021

Amount Financed

Table 3-4: Amount of Consumer Out-of-Pocket Expenditures That Are Financed, 2011–2021

Types of Expenses Financed

Figure 3-3: Distribution of Out-of-Pocket Spending for the Average Person, 2016, 2021

Figure 3-4: Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That Is Financed (All Methods), 2016 – 2021

Consumers Who Pay Out-of-Pocket

Table 3-5: Size of High Risk Groups for High Out-of-Pocket Healthcare Expenditures, 2011–2021 (Millions of Persons)

 

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
    July 13, 2023

Related products

  • Placeholder image

    Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy?

    $1,995.00 – $7,000.00
  • Placeholder image

    Organ Transplant Immunosuppressive Markets

    $995.00 – $1,990.00
  • Placeholder image

    EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

    $1,995.00 – $7,000.00
  • Placeholder image

    U.S. Market for Home Care Products, 5th Edition

    $2,995.00 – $7,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Retail Clinics 2017: The Game-Changer in HealthcareEMR Market 2017: Electronic Medical Records in an Era of Disruption
Scroll to top